Kevin Lee, Chief Executive Officer at BICYCLE THERAPEUTICS plc (BCYC), sold 99,477 shares at $32.04 ($3.3M) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Open-market sale of $3.3M BCYC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.04 | 1,936 | $62K | 1.9% |
| 2 | $32.04 | 1,936 | $62K | 1.9% |
| 3 | $32.42 | 21,979 | $713K | 21.6% |
| 4 | $32.42 | 21,979 | $713K | 21.6% |
| 5 | $33.09 | 5,788 | $192K | 5.8% |
| 6 | $33.09 | 5,788 |
| $192K |
| 5.8% |
| 7 | $34.00 | 11,194 | $381K | 11.5% |
| 8 | $32.93 | 2,642 | $87K | 2.6% |
| 9 | $32.93 | 2,642 | $87K | 2.6% |
| 10 | $33.85 | 2,686 | $91K | 2.8% |
| 11 | $33.85 | 2,686 | $91K | 2.8% |
| 12 | $34.89 | 9,084 | $317K | 9.6% |
| 13 | $34.89 | 9,084 | $317K | 9.6% |
| 14 | $35.16 | 53 | $2K | 0.1% |
| Total | $33.22 avg | 99,477 | $3.3M | 100% |
| Filing → |
| BCYC | SELL | 2026-04-06 | $38K | — | Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |